To spend any money to be on the QB for "clout" when the PPS was pre-split struggling to stay above .0001 seems a bit foolish to me.
But that's just me. What do I know?
Breaking New Ground in Medicaid Applications Brace yourself, healthcare folk! AmeriTrust Solutions just rolled out its Medicaid application platform across all 50 states, and not a minute too soon. With the ink still wet on H.R.1, hospitals and revenue cycle management (RCM) partners need all the help they can get navigating Medicaid's twisting corridors. AmeriTrust is...
Continue Reading
Robots Changing the Tiling Game Human Friendly Robotics (HFR) just dropped a game-changer—a $3.55 million deal with Foley Tile that's shaking up the tiling scene. For folks not glued to the market, this means HFR's Tyler robots are now neck-deep in Arizona soil, tasked with tiling jobs that once had the Foley crew running ragged. The Motherload of Opportunities Jerry...
Continue Reading
Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...
Continue Reading
Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...
Continue Reading
Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...
Continue Reading
Essity's Balance Act in Q3: A Close Examination No looking through rose-tinted glasses here—Essity navigated the third quarter of 2026 with mixed indicators. Despite the broad strokes of stability, there's plenty beneath the surface worth a seasoned investor's eye. The company's net sales inched up by 4.1% to SEK 36,060 million. A nice figure, sure, but if you peek...
Continue Reading
AI in Legal and Investigative Analysis: A Leap Forward Here comes Nuix with a shiny new toy—Nuix Neo AI Agent. And it ain't just any tool. This thing's built to dive through mountains of unstructured data and spit out answers backed by its trail of breadcrumbs. From legal teams to auditors and everyone in between, it'll lay out the paths it took to get to its...
Continue Reading
Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...
Continue Reading
Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...
Continue Reading
Unpacking the CRISPR/Cas9 Agreement Well, here's a fresh chapter in the realm of genetic tinkering. ERS Genomics, the gatekeeper of CRISPR licenses, has put ink to paper with KU Leuven. For those not glued to the labyrinth of genome editing, this might sound like another white-coat shuffle, but it's a pretty big deal. We're talking about CRISPR/Cas9—one of the most...
Continue Reading
Investors Take Note: Cerevel Therapeutics Holdings, Inc. Lawsuit Attention investors of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV): significant developments have emerged regarding a class action securities lawsuit which aims to address losses incurred by disgruntled shareholders. The law firm Levi & Korsinsky, LLP is spearheading this legal initiative, emphasizing...
Continue Reading
Exploring FansHash: The Future of Cloud Mining Solutions In the ever-evolving realm of the cloud mining industry, FansHash has emerged as a key player renowned for its technical prowess and dedication to user satisfaction. This professional platform not only offers efficient and secure mining solutions but also revolutionizes the industry with a robust welfare system...
Continue Reading
Innovative Partnership for Water Quality Enhancement Cadiz, Inc. is stepping forward to provide advanced perchlorate treatment tailored for the Cactus Basins Recharge Program. This initiative is a key component of a broader regional strategy aimed at enhancing groundwater banking across California. Clean Water Solutions Through Collaboration The collaboration between San...
Continue Reading
Bank of Japan Takes Notable Step with Rate Increase The Bank of Japan has adjusted its policy rate target to 0.75 percent, a significant level not seen in nearly thirty years. This action signifies a pivotal shift away from an extended period of ultra-easy monetary policy. While this rate increment was anticipated, its repercussions are expected to echo throughout global...
Continue Reading
Exploring Warren Buffett's Investment Strategies Warren Buffett, the CEO of Berkshire Hathaway, is widely regarded as one of the most esteemed investors on Wall Street. His remarkable track record showcases an astonishing cumulative return exceeding 5,650,000% for Berkshire's Class A shares since he took charge. Investors closely follow Buffett's insights into market...
Continue Reading